Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.5700 (4.9%) ($5.5700 - $5.5700) on Tue. May. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.33% (three month average) | RSI | 41 | Latest Price | $5.5700(4.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -11.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(46%) IBB(43%) ARKK(42%) ARKG(41%) XAR(39%) | Factors Impacting ATRA price | ATRA will decline at least -2.665% in a week (0% probabilities). VIXM(-41%) VXX(-24%) UNG(-19%) USO(-12%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.665% (StdDev 5.33%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-18.53(-432.68%) | Resistance Level | $6.41 | 5 Day Moving Average | $5.31(4.9%) | 10 Day Moving Average | $5.86(-4.95%) | 20 Day Moving Average | $6.41(-13.1%) | To recent high | -59.2% | To recent low | 11.6% | Market Cap | $414m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |